EP 2742154 A4 20150812 - BIOMARKER COMPOSITIONS AND METHODS
Title (en)
BIOMARKER COMPOSITIONS AND METHODS
Title (de)
BIOMARKERZUSAMMENSETZUNGEN UND VERFAHREN DAMIT
Title (fr)
COMPOSITIONS DE BIOMARQUEURS ET PROCÉDÉS
Publication
Application
Priority
- US 201161521333 P 20110808
- US 201161523763 P 20110815
- US 201161526623 P 20110823
- US 201161529762 P 20110831
- US 201161534352 P 20110913
- US 201161537462 P 20110921
- US 201161542639 P 20111003
- US 201161551674 P 20111026
- US 201161559676 P 20111114
- US 201261612111 P 20120316
- US 201261619803 P 20120403
- US 2012050030 W 20120808
Abstract (en)
[origin: WO2013022995A2] Biomarkers can be assessed for diagnostic, therapy-related or prognostic methods to identify phenotypes, such as a condition or disease, or the stage or progression of a disease, select candidate treatment regimens for diseases, conditions, disease stages, and stages of a condition, and to determine treatment efficacy. Circulating biomarkers from a bodily fluid can be used in profiling of physiological states or determining phenotypes. These include nucleic acids, protein, and circulating structures such as vesicles, and nucleic acid-protein complexes.
IPC 8 full level
C12Q 1/68 (2006.01); G01N 33/50 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01); G01N 33/574 (2006.01); G01N 33/68 (2006.01)
CPC (source: CN EP)
C12Q 1/6886 (2013.01 - CN); G01N 33/53 (2013.01 - EP); G01N 33/566 (2013.01 - EP); G01N 33/574 (2013.01 - EP); G01N 33/57434 (2013.01 - CN); G01N 33/57484 (2013.01 - CN); G01N 33/6842 (2013.01 - EP); G01N 33/6893 (2013.01 - CN); C12Q 2600/158 (2013.01 - CN); C12Q 2600/178 (2013.01 - CN); Y02A 90/10 (2017.12 - EP)
Citation (search report)
- [X] WO 2009015357 A1 20090129 - UNIV LOUISVILLE RES FOUND [US], et al
- [X] WO 2010056337 A2 20100520 - CARIS MPI INC [US], et al
- [X] WO 2008092153 A2 20080731 - UNIV LOUISVILLE RES FOUND [US], et al
- [X] T. DENG ET AL: "Abstract 444: Subpopulations of circulating microvesicles have different microRNA profiles", CANCER RESEARCH, vol. 71, no. 8 Supplement, 15 April 2011 (2011-04-15), pages 444 - 444, XP055168378, ISSN: 0008-5472, DOI: 10.1158/1538-7445.AM2011-444
- [X] TA DENG ET AL: "Subpopulations of Circulating Microvesicles Have Different MicroRNA Profiles", 7 April 2011 (2011-04-07), XP055168385, Retrieved from the Internet <URL:http://www.carislifesciences.com/media/pdf/Spetzler-sorted-MiRs-AACR-poster-2011.pdf> [retrieved on 20150209]
- [X] TRACI PAWLOWSKI ET AL: "Circulating exosomes may provide an alternate platform to monitor disease progression compared to circulating tumor cells CD-81 Labeled Exosome Level vs CTCs in Plasma Derived Exosomes miR-21 Copy Number vs CTCs in EpCAM+ Plasma Derived Exosomes", 5 July 2010 (2010-07-05), XP055168408, Retrieved from the Internet <URL:http://www.carislifesciences.com/media/pdf/ASCO_Pawlowski2010.pdf> [retrieved on 20150209]
- See references of WO 2013022995A2
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2013022995 A2 20130214; WO 2013022995 A3 20130404; AU 2012294458 A1 20140227; BR 112014002975 A2 20170301; CA 2844671 A1 20130214; CN 103874770 A 20140618; EP 2742154 A2 20140618; EP 2742154 A4 20150812; JP 2014522993 A 20140908; KR 20140067001 A 20140603
DOCDB simple family (application)
US 2012050030 W 20120808; AU 2012294458 A 20120808; BR 112014002975 A 20120808; CA 2844671 A 20120808; CN 201280049340 A 20120808; EP 12821745 A 20120808; JP 2014525128 A 20120808; KR 20147004204 A 20120808